VWF and melanoma: In vitro, addition of tumor secretomes of, for example, PC3 prostate cancer cells [164], melanoma cells (MV3, BLM) [165,166], A549 lung adenocarcinoma cells [167] and RT4 urothelial carcinoma cells [168] to ECs was observed to induce WPB secretion and thus release of VWF.